Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 600 32 331.5 |
96 | EP file number | EAKZ | 00 90 2415.9 |
86 | WO file number | WAKZ | PCT/US00/00942 |
97 | EP publication number | EPN | 1143989 |
87 | WO publication number | WPN | 2000041548 |
54 | Designation/title | TI | EXENDINE ZUR GLUCAGON SUPPRESSION |
51 | IPC main class | ICM (ICMV) | A61K 38/17 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 3/10 (2006.01) |
22 | DE application date | DAT | Jan 14, 2000 |
96 | EP application date | EAT | Jan 14, 2000 |
86 | WO application date | WAT | Jan 14, 2000 |
43 | Date of first publication | OT | Jul 20, 2000 |
| Date of publication of grant | PET | Dec 13, 2006 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
72 | Inventor | IN | YOUNG, Andrew, Point Loma, CA 92166, US; GEDULIN, Bronislava, San Diego, CA 92131, US |
74 | Representative | VTR | Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB, 80538 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000060032331T2 Searchable text:
DE000060032331T2 |
| Address for service | | Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 116380 P Jan 14, 1999
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 132017 P Apr 30, 1999
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 175365 P Jan 10, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001143989 Searchable text:
EP000001143989 Original document:
EP000001143989B1 Searchable text:
EP000001143989B1 Original document:
WO002000041548 Searchable text:
WO002000041548 |
43 | Date of first publication | EVT | Jul 20, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 16, 2020 (Show all update days)(Hide all update days)- Jan 16, 2020; Jan 12, 2019; Oct 26, 2018; Jan 23, 2018; Jan 26, 2017; Jan 26, 2016; Oct 23, 2015; Mar 27, 2015; Jan 23, 2015; Feb 11, 2014; Jan 28, 2014; Sep 24, 2013; Aug 1, 2013; Jun 11, 2013; Jun 4, 2013; Mar 1, 2013; Feb 9, 2013; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 13)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 10, 2013 |
| Issue number | HN | 31 |
| Year | PJ | 2013 |
| Publication date | VT | Aug 1, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
71/73 | Previous applicant/owner | INHF | Amylin Pharmaceuticals, LLC, San Diego, Calif., US |